Table 2. Differentially expressed genes showing increased expression in endometrial endometrioid carcinoma (n = 41).
| Gene Symbol | AEH vs. NEM | EaEC vs. NEM | AdEC vs. NEM | AdEC vs. EaEC |
|---|---|---|---|---|
| APOL1 | 0.00 | 0.34 | 2.45 | 2.12 |
| BNIP3 | −0.62 | 4.15 | 2.11 | −2.04 |
| CBS | −0.63 | 4.23 | 2.70 | −1.52 |
| CCNE2 | 2.41 | 4.27 | 3.13 | −1.14 |
| CDKN1A | 0.48 | 1.44 | 2.52 | 1.09 |
| CMPK2 | 1.03 | 3.98 | 1.76 | −2.22 |
| COL1A2 | 1.90 | −8.05 | 1.25 | 9.30 |
| CXCL2 | 0.57 | 3.85 | 2.53 | −1.33 |
| E2F3 | 2.41 | 2.48 | 1.95 | −0.52 |
| EZH2 | 2.92 | 2.97 | 3.01 | 0.04 |
| EZR | 1.46 | 3.34 | 2.01 | −1.34 |
| FREM2 | 0.30 | −4.46 | 4.01 | 8.47 |
| GCLM | −0.01 | 2.32 | 2.12 | −0.20 |
| GPT2 | 0.49 | 1.40 | 2.44 | 1.04 |
| HOMER2 | 1.13 | 0.07 | 2.21 | 2.14 |
| HOXA9 | −0.58 | −4.02 | 2.53 | 6.55 |
| KIF1A | 0.13 | 2.11 | 2.19 | 0.08 |
| LIF | 2.02 | 2.47 | 2.02 | −0.46 |
| LIX1 | −1.04 | 0.13 | 2.21 | 2.08 |
| MT1M | −0.28 | 2.10 | 1.85 | −0.25 |
| NANOS1 | −0.09 | 3.11 | 2.21 | −0.89 |
| OPRK1 | −0.98 | −1.03 | 5.66 | 6.69 |
| PACSIN1 | 1.88 | 2.26 | 2.19 | −0.07 |
| PGK1 | −0.20 | 2.51 | 1.84 | −0.67 |
| PLAU (uPA) | 0.42 | 0.90 | 2.40 | 1.50 |
| PLCXD2 | −0.20 | 2.66 | 2.12 | −0.54 |
| PLOD2 | 0.69 | 3.07 | 2.13 | −0.94 |
| PSAT1 | 0.44 | 1.84 | 3.65 | 1.81 |
| PTGS2 | 0.29 | 0.66 | 3.50 | 2.84 |
| PTPRJ | 0.15 | 2.33 | 1.85 | −0.48 |
| RAB11FIP4 | −0.11 | 2.11 | 2.10 | −0.01 |
| RCC1 | 2.29 | 1.55 | 1.75 | 0.20 |
| RIMKLA | −0.37 | 2.07 | 1.77 | −0.30 |
| SLC2A1 | 1.50 | 4.42 | 3.09 | −1.33 |
| SLC7A1 | 1.08 | 0.72 | 2.17 | 1.45 |
| ST14 | 1.40 | 3.12 | 2.55 | −0.57 |
| STAT1 | 0.21 | 1.91 | 2.26 | 0.35 |
| TFAP2A | 1.44 | 2.62 | 4.23 | 1.61 |
| TTYH2 | 1.15 | 2.10 | 1.88 | −0.21 |
| VCAM1 | −1.77 | −3.94 | 2.44 | 6.38 |
| VDR | 1.34 | 1.77 | 3.16 | 1.39 |
Data presented as a log2 (fold change)
Abbreviations: NEM, normal endometrium; AEH, atypical endometrial hyperplasia; EaEC, early stage endometrioid carcinoma; AdEC, advanced stage endometrioid carcinoma